Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review

References

• Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55–63.
   PubMed Web of Science ®Google Scholar
• Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost. 1981;45:200–3.
   PubMed Web of Science ®Google Scholar
• Ma AD, Carrizosa D. Acquired factor VIII inhibitors: patho-physiology and treatment. Hematology Am Soc Hematol Educ Program. 2006;432–7.
   Google Scholar
• Pimer K, Rosler W, Kalden JR, Manger B. Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus. Z Rheu-matol. 1990;49:378–81.
   Google Scholar
• Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood. 1995;86:797–804.
   Google Scholar
• Schulman S, Langevitz P, Livneh A, Mortinowitz U, Seligsohn U, Varon D. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost. 1996;76:344–6.
   PubMed Web of Science ®Google Scholar
• Lafferty TE, Smith JB, Schuster SJ, DeHoratius RJ. Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:775–8.
   Google Scholar
• Trotta F, Bajocchi G, La Corte R, Moratelli S, Sun LY. Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus. Rheumatology (Oxford). 1999;38:1007–9.
   Google Scholar
• Ishikawa T, Tsukamoto N, Suto M, Uchiumi H, Mitsuhashi H, Yokohama A, et al. Acquired hemophilia A in a patient with systemic lupus erythematosus. Intern Med. 2001;40:541–3.
   Google Scholar
• Nishino Y, Ueki K, Suto M, Uchiumi H, Ota F, Tamura S, et al. Successful treatment of patients with rheumatic disorders and acquired factor VIII inhibitors with cyclophosphamide and prednisolone combination therapy: two case reports. J Int Med Res. 2001;29:432–6.
   PubMedGoogle Scholar
• Komfeld S, Veyssier-Belot C, Vinceneux A, Renier JL, Du-Boutin le TH, Pauwels C. Acquired haemophilia in a patient with systemic lupus erythematosus. Ann Dermatol Venereol. 2002;129:316–9.
   Google Scholar
• Onishi S, Hojo N, Sakai I, Yasukawa M, Hato T, Minamoto Y, et al. Rupture of the gallbladder in a patient with acquired factor VIII inhibitors and systemic lupus erythematosus. Intern Med. 2004;43:1073–7.
   PubMed Web of Science ®Google Scholar
• Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost. 1993;70:753–7.
   Google Scholar
• Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglob-ulin. Lancet. 1984;2:765–8.
   PubMed Web of Science ®Google Scholar
• Francesconi M, Kominger C, Thaler E, Niessner H, Hocker P, Lechner K. Plasmapheresis: its value in the management of patients with antibodies to factor VIII. Haemostasis. 1982;11:79–86.
   PubMedGoogle Scholar
• Freedman J, Garvey MB. Immunoadsorption of factor VIII inhibitors. Curr Opin Hematol. 2004;11:327–33.
   PubMed Web of Science ®Google Scholar
• Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulat-ing concept. Blood. 2005;105:2287–93.
   PubMed Web of Science ®Google Scholar
• Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired F VIII:C inhibitors. Br J Haematol. 1981;48:635–42.
   PubMed Web of Science ®Google Scholar
• Herbst KD, Rapaport SI, Kenoyer DG, Stanton W, Feinstein DI. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone. Ann Intern Med. 1981;95: 575–8.
   Google Scholar
• Kain S, Copeland TS, Leahy MF. Treatment of refractory auto-immune (acquired) haemophilia with anti-CD20 (rituximab). Br J Haematol. 2002;119: 578.
   Google Scholar
• Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peer-schke El, et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood. 2002;100:3426–8.
   Google Scholar
• Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood. 2004;103:4424–8.
   PubMed Web of Science ®Google Scholar
• Hart HC, Kraaijenhagen RJ, Kerckhaert JA, Verdel G, Freen M, van de Wiel A. A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine. Transplant Proc. 1988;20:323–8.
   Google Scholar
• Pfliegler G, Boda Z, Harsfalvi J, Flora-Nagy M, Sari B, Pecze K, et al. Cyclosporin treatment of a woman with acquired haemo-philia due to factor VIII:C inhibitor. Postgrad Med J. 1989;65:400–2.
   Google Scholar
• Brox AG, Laryea H, Pelletier M. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol. 1998;57:87–8.
   Google Scholar
• Petrovic M, Derom E, Baele G. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. Haematolog-ica. 2000;85:895–6.
   Google Scholar
• Au WY, Lam CC, Kwong YL. Successful treatment of acquired factor VIII inhibitor with cyclosporin. Haemophilia. 2004;10:98–100.
   Google Scholar
• Maize JC Jr, Cohen JB. Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII defi-ciency. Int J Dermatol. 2005;44:692–4.
   Google Scholar
• Pardos-Gea J, Ordi-Ros J, Altisent C, Balada E, Perez-Lopez J, Vilardell M. Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclo-sporin. Thromb Haemost. 2006;95:735–7.
   PubMed Web of Science ®Google Scholar
• 'Thatayatikom A, White AJ. Rituximab: a promising therapy in systemic lupus erythematosus. Autoimmun Rev. 2006;5: 18–24.
   Google Scholar
• Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2:20–7.
   PubMedGoogle Scholar
• Aggarwal A, Grewal R, Green RJ, Boggio L, Green D, Weksler BB, et al. Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia. 2005;11:13–9.
   PubMed Web of Science ®Google Scholar